These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8059423)

  • 1. Comments on "Cardiovascular birth defects and prenatal exposure to female sex hormones".
    Wiseman RA
    Teratology; 1994 Mar; 49(3):172-3; discussion 174-7. PubMed ID: 8059423
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiovascular birth defects and prenatal exposure to female sex hormones: importance of utilizing proper epidemiological methods and teratologic principles.
    Brent RL
    Teratology; 1994 Mar; 49(3):159-61. PubMed ID: 8059420
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiovascular birth defects and prenatal exposure to female sex hormones: a reevaluation of data reanalysis from a large prospective study.
    Hook EB
    Teratology; 1994 Mar; 49(3):162-6. PubMed ID: 8059421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular birth defects and prenatal exposure to female sex hormones: a reevaluation of data reanalysis from a large prospective study.
    Hook EB
    Teratology; 1992 Sep; 46(3):261-6. PubMed ID: 1523583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular birth defects and antenatal exposure to female sex hormones.
    Hadjigeorgiou E; Malamitsi-Puchner A; Lolis D; Lazarides P; Nicolopoulos D; Kaskarelis D
    Dev Pharmacol Ther; 1982; 5(1-2):61-7. PubMed ID: 7151638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analyses and reanalyses of epidemiologic data: learning lessons and maintaining perspective.
    Mitchell AA; Werler MM; Shapiro S
    Teratology; 1994 Mar; 49(3):167-8; discussion 169-71. PubMed ID: 8059422
    [No Abstract]   [Full Text] [Related]  

  • 7. Analyses and reanalyses of epidemiologic data: learning lessons and maintaining perspective.
    Mitchell AA; Werler MM; Shapiro S
    Teratology; 1992 Sep; 46(3):209-11. PubMed ID: 1523577
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiovascular birth defects and antenatal exposure to female sex hormones: a reevaluation of some base data.
    Wiseman RA; Dodds-Smith IC
    Teratology; 1984 Dec; 30(3):359-70. PubMed ID: 6240131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neonatal malformations and hormone therapy during pregnancy].
    Pacilli L; Graffino W; Arrotta S
    Minerva Ginecol; 1981; 33(7-8):659-65. PubMed ID: 7290498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital abnormalities and hormones during pregnancy: a clinical review.
    Schardein JL
    Teratology; 1980 Dec; 22(3):251-70. PubMed ID: 7015547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidepressant drugs during pregnancy and infant congenital heart defect.
    Källén B; Otterblad Olausson P
    Reprod Toxicol; 2006 Apr; 21(3):221-2. PubMed ID: 16406480
    [No Abstract]   [Full Text] [Related]  

  • 12. Maternal exposure to exogenous progestogen/estrogen as a potential cause of birth defects.
    Nora AH; Nora JJ
    Adv Plan Parent; 1978; 12(3):156-69. PubMed ID: 640221
    [No Abstract]   [Full Text] [Related]  

  • 13. Application of pharmacogenomic strategies to the study of drug-induced birth defects.
    Leeder JS; Mitchell AA
    Clin Pharmacol Ther; 2007 Apr; 81(4):595-9. PubMed ID: 17314924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex hormones and congenital malformations: a review.
    Nelson KG; Goldenberg RL
    J Med Assoc State Ala; 1977 May; 46(11):31. PubMed ID: 864346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular birth defects and antenatal exposure to female sex hormones.
    Heinonen OP; Slone D; Monson RR; Hook EB; Shapiro S
    N Engl J Med; 1977 Jan; 296(2):67-70. PubMed ID: 830309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug exposure in pregnancy and heart defects.
    Matok I; Pupco A; Koren G
    J Cardiovasc Pharmacol; 2011 Jul; 58(1):20-4. PubMed ID: 21499119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal asthma, asthma medication use, and the risk of congenital heart defects.
    Lin S; Herdt-Losavio M; Gensburg L; Marshall E; Druschel C
    Birth Defects Res A Clin Mol Teratol; 2009 Feb; 85(2):161-8. PubMed ID: 19067406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epidemiologic methods in teratology].
    Saxén L; Karkinen-Jääskeläinen M; Saxén I
    Duodecim; 1974; 90(22):1554-64. PubMed ID: 4455479
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancy.
    Einarson A; Pistelli A; DeSantis M; Malm H; Paulus WD; Panchaud A; Kennedy D; Einarson TR; Koren G
    Am J Psychiatry; 2008 Jun; 165(6):749-52. PubMed ID: 18381907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal drugs and the risk of selected birth defects.
    Carter TC; Druschel CM; Romitti PA; Bell EM; Werler MM; Mitchell AA;
    Am J Obstet Gynecol; 2008 Feb; 198(2):191.e1-7. PubMed ID: 18226621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.